ReviewRSC advances2025
Recent advances of silver nanoparticle-based polymer nanocomposites for biomedical applications.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed.
- Article
- Are Silver and Gold Nanoparticles Obtained by 'Green' Synthesis Biocompatible?Nanomaterials (Basel, Switzerland) · 2026Review
- Silver Release Diffusion Modeling and Biological Performance of Poly(Vinyl Alcohol)/Alginate Hydrogels with Embedded Silver Nanoparticles.Molecules (Basel, Switzerland) · 2026Article
- Hybrid Sonochemical-Pressure Fabrication of tri-element nanohybrids for advanced biological protection in resin and metal dental crowns.Ultrasonics sonochemistry · 2026Article
- Myco-synthesized silver nanoparticles from Aspergillus niger AH1 as multifunctional anti-Helicobacter pylori agents: Antibacterial, antibiofilm, anti-urease, and antibiotic-synergistic activities.Folia microbiologica · 2026Article
- Article
- Silver-based N-heterocyclic carbene (NHC) complexes as emerging strategies against antimicrobial resistance.Archives of microbiology · 2026Review
- Comparative Mechanical and Thermal Performance of Graphene- and Silver Nanoparticle-Reinforced PLA Fabricated by FDM 3D Printing.Polymers · 2026Article
- Green Chitosan Bioplastics: How the Filler Impacts the Biological Activity and the Biodegradability?Materials (Basel, Switzerland) · 2026Article
- Bioengineered Silver Nanoparticles: Next-Generation Biogenic Synthesis Strategies for Precision Biomedical Applications.Bioengineering (Basel, Switzerland) · 2026Review
- Phytochemical Profiling and Green Synthesis of Silver Nanoparticles fromMolecules (Basel, Switzerland) · 2026Article
- Green synthesis of silver nanoparticles using Achillea arabica and their antioxidant, anti-inflammatory, antidiabetic, and antimicrobial activities.Discover nano · 2026Article
- Synthesis of Prussian Blue-Containing Polymeric Nanocapsules via Interfacial Confined Coordination in Crosslinked Miniemulsion.Nanomaterials (Basel, Switzerland) · 2026Article
- Biosynthesis of Silver Nanoparticles from Hybrid Polymer: Characterization, Approach from XRD and Investigation of Antimicrobial Activity.ACS omega · 2026Article
- Mechanistic advances in microbial nanobiotechnology and their applications in sustainable agriculture, environment and biomedicine.Discover nano · 2026Review
- Contact-Dependent Antibacterial Performance of Silver Nanoparticles Encapsulated in Collagen-Based Gels.Journal of functional biomaterials · 2026Article
- Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Tri-Layer Composite Nanofiber Wound Dressing Incorporating Glucantime and Silver Nanoparticles for Cutaneous Leishmaniasis Management.Journal of functional biomaterials · 2026Article
- Antimicrobial Properties of Polymer-Based Nanocomposites Modified by Nanoparticles Produced by Green Chemistry.Materials (Basel, Switzerland) · 2026Article
- Organic Polyurethane Surface Structures to Manufacture Noneluting Antimicrobial Polyurethanes: A Systematic Review of Literature.BioMed research international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticle-polymer nanocomposites (AgNP-PNCs) represent a transformative advancement in biomedical material science, integrating the potent antimicrobial properties of AgNPs with the structural versatility of polymer matrices. This synergy enables enhanced infection control, mechanical stability, and controlled drug delivery, making these nanocomposites highly suitable for applications such as wound healing, medical coatings, tissue engineering, and biosensors. Recent progress in synthesis and functionalization has led to greater control over particle morphology, dispersion, and stability, optimizing AgNP-PNCs for clinical and translational applications. However, challenges related to cytotoxicity, long-term stability, immune response, and scalability persist, necessitating systematic improvements in surface functionalization, hybridization strategies, and biocompatibility assessments. This review critically evaluates the latest advancements in AgNP-PNC development, focusing on their functionalization techniques, regulatory considerations, and emerging strategies to overcome biomedical challenges. Additionally, it discusses preclinical and translational aspects, including commercialization barriers and regulatory frameworks such as FDA and EMA guidelines, ensuring a comprehensive outlook on their clinical feasibility. By bridging the gap between innovation and practical application, this review investigates the transformative potential of AgNP-PNCs in advancing next-generation biomedical materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.